ID   AA-2
AC   CVCL_8168
SY   AA2
DR   HIVReagentProgram; ARP-135
DR   Wikidata; Q54607564
RX   PubMed=3261775;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
RX   PubMed=3261775; DOI=10.1084/jem.168.2.605;
RA   Chaffee S., Leeds J.M., Matthews T.J., Weinhold K.J., Skinner M.,
RA   Bolognesi D.P., Hershfield M.S.;
RT   "Phenotypic variation in the response to the human immunodeficiency
RT   virus among derivatives of the CEM T and WIL-2 B cell lines.";
RL   J. Exp. Med. 168:605-621(1988).
//